Alcohol use while on the liver transplant waiting list: A single-center experience

Authors

  • Michelle Carbonneau,

    1. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    2. Department of Nursing, University of Alberta, Edmonton, Alberta, Canada
    3. Department of Liver Transplantation Unit, University of Alberta, Edmonton, Alberta, Canada
    Search for more papers by this author
  • Louise A. Jensen,

    1. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    2. Department of Nursing, University of Alberta, Edmonton, Alberta, Canada
    Search for more papers by this author
  • Vincent G. Bain,

    1. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    2. Department of Liver Transplantation Unit, University of Alberta, Edmonton, Alberta, Canada
    Search for more papers by this author
  • Karen Kelly,

    1. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    2. Department of Nursing, University of Alberta, Edmonton, Alberta, Canada
    Search for more papers by this author
  • Glenda Meeberg,

    1. Department of Liver Transplantation Unit, University of Alberta, Edmonton, Alberta, Canada
    Search for more papers by this author
  • Puneeta Tandon

    Corresponding author
    1. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    2. Department of Liver Transplantation Unit, University of Alberta, Edmonton, Alberta, Canada
    • 130 University Campus, Zeidler Ledcor Center, University of Alberta, Edmonton, Alberta T6G 2X8, Canada
    Search for more papers by this author
    • Telephone: 780-492-9844; FAX: 780-492-9873


Abstract

Alcoholic liver disease (ALD) is a leading indication for liver transplantation. Our center has randomly checked blood alcohol levels (BALs) in ALD patients on the waiting list since 2004. We aimed to identify the incidence and predictors of inactivation on the transplant list due to alcohol use and to determine the utility of BAL-screening in this process. We conducted a retrospective review of patients with ALD listed for liver transplantation with at least 3 months of postlisting follow-up. Alcohol use while on the transplant list was defined as a positive BAL, an admission of alcohol use, or refusal to perform screening within 12 hours of request. Cox proportional hazards regression was used to estimate risk ratios (RRs). Of 134 patients meeting eligibility criteria, 78% were male, and mean age was 52 years. Alcohol use was documented in 23 patients (17%). Of these, 12 refused to have a random screen, 8 had detectable serum ethanol levels, and 3 had self-reported alcohol use. On multivariable analysis, a higher number of random BAL-checks [RR = 0.63(0.52, 0.76), P = 0.001] and a longer duration of prelisting abstinence [RR = 0.88(0.83, 0.94), P = 0.001] independently reduced the risk of alcohol use by patients while on the waiting list. None of the patients with >24 months of prelisting abstinence had a positive screen. In conclusion, this study supports random BAL-screening before transplantation and reinforces the importance of abstinence duration as a predictor of relapse. For patients with <24 months of prelisting abstinence, our center will increase the frequency of random BAL screening and increase the rehabilitation requirements to include an intensive 3-week rehabilitation program. We hope that these measures will reduce the rate of relapse to alcohol use post-transplantation. Liver Transpl 16:91–97, 2010. © 2009 AASLD.

Ancillary